Improving Participation in HIV Clinical Trials: Impact of a Brief Intervention
- 1 June 2001
- journal article
- research article
- Published by Informa UK Limited in HIV Research & Clinical Practice
- Vol. 2 (3), 205-212
- https://doi.org/10.1310/phb6-2eya-ga06-6bp7
Abstract
Purpose: To determine if a brief intervention that provides information about AIDS clinical trials to HIV-infected patients at the initiation of primary care increases the participation of women, persons of color, and injection drug users (IDUs) in clinical trials. Method: 196 outpatients beginning HIV primary care at a municipal hospital were followed from September 1994 to April 1996. During the intake assessment, each patient met briefly with a research assistant who described the purpose, role, and availability of clinical trials. Contacts for further information about trials were given to patients who expressed interest. At the end of the 20-month period, enrollment rates of all patients, including women, persons of color, and IDUs, into clinical trials were compared with previously published enrollment rates of patients at the same hospital but prior to the development of this brief intervention. Results: The characteristics of the 196 HIV-infected patients were: 27% women; 47% IDUs; 14% gay/bisexual men; and 76% persons of color. Overall enrollment in AIDS clinical trials was 14.8% during the 20-month follow-up period. There was no significant difference in participation rates between males and females (p = .20), whites and persons of color (p = .71), and IDUs compared with non-IDUs (p = .90), whereas previously published data had shown significantly higher enrollment rates among males, whites, and non-IDUs. Conclusion: Providing all HIV-infected patients with information about the meaning, role, and availability of AIDS clinical trials at the initiation of HIV primary care reduces differences in participation rates by gender, race, and history of drug use.Keywords
This publication has 17 references indexed in Scilit:
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Differences in Participation in Experimental Drug Trials Among Persons With AIDSJAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
- Scope of the AIDS Epidemic in the United StatesScience, 1995
- Women in Clinical Trials of New Drugs -- A Change in Food and Drug Administration PolicyNew England Journal of Medicine, 1993
- Enrollment of Drug Abusers in HIV Clinical Trials: A Public Health Imperative for Communities of ColorJournal of Psychoactive Drugs, 1993
- Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinicAmerican Journal Of Medicine, 1992
- The challenge of minority recruitment in clinical trials for AIDSPublished by American Medical Association (AMA) ,1992
- Women and HIV/AIDS ResearchEvaluation Review, 1990
- The Regulation of Investigational DrugsNew England Journal of Medicine, 1989